Skip to main content Accessibility help

Association of Antibiotic Utilization Measures and Control of Multiple-Drug Resistance in Klebsiella pneumoniae

  • Jan E. Patterson (a1), Thomas C. Hardin (a1), Cindy A. Kelly (a1), Rosa C. Garcia (a1) and James H. Jorgensen (a1)...



To study the association of antibiotic-utilization measures and control of multidrug-resistant (MDR) Klebsiella pneumoniae after emergence in two hospitals in our medical center.

Design and Setting:

Rates of MDR K pneumoniae at two hospitals were compared before and after acute interventions, including emphasis on Contact Precautions and education in antibiotic utilization. Antipseudomonal β-lactam antibiotic use was measured before and after the interventions at both hospitals. Pulsed-field gel electrophoresis of whole cell DNA was used as a marker of strain identity.


Clonal strain dissemination was the major mechanism of emergence at hospital A; emergence was polyclonal at hospital B. Antibiotic-utilization interventions at both institutions included physician education regarding the association of ceftazidime use and MDR K pneumoniae. At hospital A, ceftazidime use decreased from 4,301 g in the preintervention period, to 1,248 g in the postintervention period. Piperacillin-tazobactam use increased from 12,455 g to 17,464 g. Ceftazidime resistance in Kpneumoniae decreased from 110 (22%) of 503 isolates to 61 (15%) of 407 isolates (P<.05); piperacillin-tazobactam resistance decreased from 181 (36%) of 503 to 77 (19%) of 407 isolates (P<.05). At hospital B, ceftazidime use decreased from 6,533 g in the preintervention period to 4,792 g in the postintervention period. Piperacillin-tazobactam use increased from 58,691 g to 67,027 g. Ceftazidime resistance in K pneumoniae decreased from 42 (10%) of 415 isolates to 19 (5%) of 383 isolates (P<.05). Piperacillin-tazobactam resistance decreased from 91 (22%) of 415 isolates to 54 (14%) of 383 isolates (P<.05). Follow-up data showed continued decrease in piperacillin-tazobactam resistance despite increased use at both hospitals.


Antibiotic-use measures may be particularly important for control of MDR K pneumoniae, whether emergence is clonal or polyclonal.


Corresponding author

Dept of Medicine (Infectious Diseases), 7703 Floyd Curl Dr, Mail Code 7881, San Antonio, TX, 78229-3900


Hide All
1. Jacoby, G. Extended-spectrum-β-lactamases and other enzymes providing resistance to oxyimino-β-lactams. Infect Dis Clin North Am 1997;11:875887.
2. Horii, T, Arakawa, Y, Ohta, M, Ichiyama, S, Wacharotayankun, R, Kato, N. Plasmid-mediated AmpC-type β-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including mox-alactam. Antimicrob Agents Chemother 1993;37:984990.
3. Gazouli, M, Kaufmann, ME, Tzelepi, E, Dimopoulou, H, Paniara, O, Tzouvelekis, LS. Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J Clin Microbiol 1997;35:508510.
4. Nouvellon, M, Pons, JL, Sirot, D, Combe, ML, Lemeland, JF. Clonal outbreaks of extended-spectrum β-lactamase-producing strains of Klebsiella pneumoniae demonstrated by antibiotic susceptibility testing, β-lactamase typing, and multilocus enzyme electrophoresis. J Clin Microbiol 1994;32:26252627.
5. Rice, LB, Willey, SH, Papanicolaou, GB, Medeiros, AA Eliopoulos, GM, Moellering, RC, et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990;34:21932199.
6. Bingen, EH, Desgardins, P, Arlet, G, Bourgeois, F, Mariani-Kurkdjian, P, Lambert-Zechovsky, NY, et al. Molecular epidemiology of plasmid spread among extended broad-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital. J Clin Microbiol 1993;31:179184.
7. Rice, LB, Eckstein, EC, DeVente, J, Shlaes, DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;223:118124.
8. Rahal, JJ, Urban, C, Horn, D, Freeman, K, Segal-Maurer, S, Maurer, J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella . JAMA 1998;280:12331237.
9. National Committee on Clinical Laboratory Standards, M100-S8. Document Wayne, PA: NCCLS; 1998.
10. Sanders, CC, Barry, AL, Washington, JA, Shuber, C, Moland, ES, Traczewski, MM, et al. Detection of the extended-spectrum-β-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test. J Clin Microbiol 1996;34:29973001.
11. Jarlier, V, Nicolas, MH, Fournier, G, Philippon, A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867878.
12. Tenover, FC, Arbeit, RD, Goering, RV, Mickelsen, PA, Murray, BE, Persing, DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:22332239.
13. Monnet, DL, Biddle, JW, Edwards, JR, Culver, DH, Tolson, JS, Martone, WJ, et al. Evidence of interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. Infect Control Hosp Epidemiol 1997;18:492498.


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed